Search News Archives
Follow us on
Conferences | Events
Lab Bulletin Media Partners
Gyros AB

Gyros AB

Gyros AB

Products

Contact Gyros AB


If you have not logged into the website then please enter your details below.

All articles from Gyros AB

  Gyros Protein Technologies Introduces Gyrolab CHO-HCP E3G Kit for Impurity Testing of Biotherapeutics

gyrosIncorporates Cygnus Technologies’ gold standard reagents. Ready-to-use immunoassay kit designed to increase productivity. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls) – bioprocess workflow of biotherapeutics...

 

  Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

GyrosGyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Cygnus Technologies, the leading assay and services provider for the detection and characterization...

 

  Gyros Protein Technologies Installs two Gyrolab xPlore Systems at Oxford BioMedica for Gene and Cell Therapy Applications

Gyros


Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, has  announced Oxford BioMedica® plc, a leading gene and cell therapy group, has invested in two Gyrolab xPlore™ systems....

 

  Gyros Protein Technologies Introduces Gyrolab xPand to Improve Immunoassay Workflow, Flexibility and Speed in Biotherapeutic Discovery, Development and Production

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassay platforms and leading provider of peptide synthesizers and reagents, has introduced a new 5 CD model, Gyrolab® xPand, in response to customer requests to provide higher throughput, greater flexibility and faster analysis of large sample numbers....

 

  Gyros Protein Technologies and Fleet Bioprocessing Partner to Offer Assay Development and Transfer Services

Fleet to provide support for Gyrolab platform users in developing, transferring and optimizing assays. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Fleet Bioprocessing Ltd. (Fleet), an expert provider of contract immunoassay development services and immunoassay reagent manufacture...

 

  Gyros Protein Technologies Introduces Multi-Species Kit for Toxicokinetic Studies

gyrosGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studies. The new Gyrolab® Generic TK Kit adds to a growing menu of ready-to-use kits, and allows researchers to more efficiently quantify human therapeutic antibodies (IgG) in automated, nanoliter-scale Gyrolab xP and Gyrolab xPlore™ systems....

 

  Gyros Protein Technologies Signs Distribution Agreement with Euro Diagnostica

Gyros Protein Technologies becomes distributor of iLite cell-based reporter gene assays for drug development

gyrosGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, has announced it has signed a distribution agreement with Euro Diagnostica, the full service assay solution company....

 

  Gyros Protein Technologies Introduces New ADA Solution for Immunogenicity Market

Developed to supportassay development and validation for detection of anti-drug antibodies

gyrosGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, has announced it has launched a new version of its anti-drug antibody(ADA)solution for the immunogenicity market....

 

  Gyros Protein Technologies Introduces Next Generation Gyrolab Protein A Kit for Biotherapeutics

Kit increases efficiency of residual protein A ligand detection

gyrosGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has launched a new version of its Gyrolab™ Protein A Kit. The new Protein A Kit offers increased efficiency and throughput for quantification of residual Protein A ligands...

 

  Gyros Protein Technologies Signs Distribution Agreement with Luxembourg Bio Technologies for Peptide Synthesis Reagents

Agreement includes exclusive distribution of PurePep Coupling Agents in North America

gyrosGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced it has signed an exclusive distribution agreement with Luxembourg Bio Technologies for two of its proprietary coupling agents, PyOxim® and K-Oxyma®, and HDMA on a non-exclusive basis...

 

  Gyros Protein Technologies Introduces a Multi-Species Kit for Pharmacokinetic Studies

New kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems

gyrosGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new kit for early-stage biotherapeutic pharmacokinetic (PK) studies....

 

  Gyros Protein Technologies and Abacus ALS Sign Distribution Agreement

Abacus will distribute Gyrolab™ immunoassay products in Australia and New Zealand

gyrosGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today that it has appointed Abacus ALS as exclusive distributor of its immunoassay products in Australia and New Zealand....

 

  Gyros Protein Technologies Establishes Dedicated Office in Japan

Gyros Japan KK provides sales, field applications and service for the immunoassay business

Gyros ProteinGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has established a dedicated office in Tokyo, Japan and has established Gyros Japan KK....

 

  Gyros AB Extends Capabilities of Gyrolab Automated Immunoassay Platform with New Affinity Software Module

New software module supports in-solution affinity characterization at nanoliter-scale

gyrosGyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, today announced the release of Gyrolab™ Affinity Software Module, which is available on both Gyrolab xP workstation and the recently launched single CD Gyrolab xPlore. The new, intuitive software module enables users to easily set up and run in-solution affinity determinations of up to 14 interacting pairs in parallel in just one hour...

 

  Gyros Introduces Series of Kits for Bioprocess Analysis

Expanded kit offering strengthens position of Gyrolab automated solution for analysis in bioprocess workflows

Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, today introduced a series of new kits for analysis in bioprocess workflows. The new kits comprise Gyrolab™ CHO-HCP Kits 2-5 and two Gyrolab Human IgG Titer Kits for rapid quantification of IgG. Combined with the automation and high throughput of Gyrolab systems, GyrolabxP workstation and Gyrolab xPlore™, these kits facilitate increased productivity in...

 

  Gyros Introduces Gyrolab CHO-HCP Kit 1 for Detection and Quantification of Host Cell Proteins in Bioprocessing

Nanoliter-scale kit rapidly and easily detects and quantifies host cell proteins from Chinese hamster ovary cells

Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, today announced the introduction of its Gyrolab™ CHO-HCP Kit 1. The new kit detects and quantifies host cell proteins (HCP) from Chinese hamster ovary (CHO) cells used in bioprocessing of biotherapeutics. HCP are measured throughout the production process, as they may affect the safety and efficacy of the biotherapeutic....

 

  Gyros Launches Gyrolab Protein A Kit for Efficient Quantification of Residual Protein A

Optimized kit for use with Gyros immunoassay platform

protein a kitGyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, today announced the launch of its Gyrolab™ Protein A Kit for use on Gyrolab xP workstation. During purification of biotherapeutics, Protein A can leach from the chromatography support and co-elute with the therapeutic antibody product. The contamination complicates subsequent analysis using immunoassays....

 

  Merck Millipore Partners with Gyros to Develop, Manufacture and Commercialize Kits on the Gyrolab Immunoassay Platform

Simple, automated, nanoliter-scale assays requiring as little as 1uL of sample. Ready-to-use kits are fully validated for reliable use in clinical research. Accuracy and precision meet or exceed ELISA performance.

Gyrolab Immunoassay PlatformMerck Millipore, the Life Science division of Merck, today announced a partnership with Gyros AB to develop, manufacture and commercialize immunoassay kits for the Gyrolab™ platform. The new, fully validated kits from Merck Millipore will enable clinical researchers and drug developers to generate valuable research data much faster than typical ELISA kits. Traditional ELISAs can consume significant time, sample and reagents. With the fully automated, walk-away system from Gyros, up to 560 data points can be generated in a run...

 

  Gyros platform integrated into second, US-based, contract research organization Gyros AB, a leader in the automation of miniaturized immunoassays, confirmed today that Radix BioSolutions, a US-based contract research organization specializing in custom assay development, reagent manufacturing, and a provider of assay services, will integrate a Gyrolab™ xP workstation into their immunoassay development programs.

 

  Gyros platform enters leading US Clinical Research Organization Gyros AB, a leader in the automation of miniaturized immunoassays, confirmed today that CEDRA Corporation has become the first North American Clinical Research Organization to incorporate a GyrolabTM xP workstation into their offering for the biopharmaceutical industry.

 

 

  Gyros and SCRUM sign distribution agreement for the Japanese market Gyros® AB, the leading provider of automated micro-immunoassays for the development of biotherapeutics, is pleased to announce the signing of an exclusive distribution agreement with SCRUM, a major supplier to the Japanese life-science market.